This growth equity financing was led by new investor Jolt Capital (HQ Paris),
The new financing will help accelerate the expansion of the company’s data footprint, consolidating the company’s position as the leading European data provider, and enabler of personalized precision medicine, with a focus on sourcing clinically valuable Real-World Data (RWD) from European and Asian countries.
Access to their full press release here